113 related articles for article (PubMed ID: 4073850)
1. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease.
Matzuk MM; Saper CB
Ann Neurol; 1985 Nov; 18(5):552-5. PubMed ID: 4073850
[TBL] [Abstract][Full Text] [Related]
2. Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease.
Saper CB; Sorrentino DM; German DC; de Lacalle S
Ann Neurol; 1991 Jun; 29(6):577-84. PubMed ID: 1892359
[TBL] [Abstract][Full Text] [Related]
3. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
Hirsch E; Graybiel AM; Agid YA
Nature; 1988 Jul; 334(6180):345-8. PubMed ID: 2899295
[TBL] [Abstract][Full Text] [Related]
4. Specific A10 dopaminergic nuclei in the midbrain degenerate in Parkinson's disease.
McRitchie DA; Cartwright HR; Halliday GM
Exp Neurol; 1997 Mar; 144(1):202-13. PubMed ID: 9126172
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
6. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
7. An altered histaminergic innervation of the substantia nigra in Parkinson's disease.
Anichtchik OV; Rinne JO; Kalimo H; Panula P
Exp Neurol; 2000 May; 163(1):20-30. PubMed ID: 10785440
[TBL] [Abstract][Full Text] [Related]
8. Striatal dopaminergic neurons are lost with Parkinson's disease progression.
Porritt MJ; Kingsbury AE; Hughes AJ; Howells DW
Mov Disord; 2006 Dec; 21(12):2208-11. PubMed ID: 17029264
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the projections to the hypothalamic paraventricular and periventricular nuclei in the female sheep brain, using retrograde tracing and immunohistochemistry.
Qi Y; Namavar MR; Iqbal J; Oldfield BJ; Clarke IJ
Neuroendocrinology; 2009; 90(1):31-53. PubMed ID: 19478473
[TBL] [Abstract][Full Text] [Related]
10. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.
Rodríguez M; Barroso-Chinea P; Abdala P; Obeso J; González-Hernández T
Exp Neurol; 2001 May; 169(1):163-81. PubMed ID: 11312569
[TBL] [Abstract][Full Text] [Related]
11. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics.
Bogerts B; Häntsch J; Herzer M
Biol Psychiatry; 1983 Sep; 18(9):951-69. PubMed ID: 6640008
[TBL] [Abstract][Full Text] [Related]
12. [Compensatory reaction during degeneration of arcuate nucleus dopaminergic neurons in rats].
Ziiazetdinova GZ; Sapronova AIa; Kiiasova VIa; Nanaev AK; Kudrin VS; Martina N; Tyllet I; Ugriumov MV
Zh Evol Biokhim Fiziol; 2008; 44(1):72-7. PubMed ID: 18411516
[TBL] [Abstract][Full Text] [Related]
13. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2008 Jul; 23(10):1407-13. PubMed ID: 18581481
[TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus.
Swanson LW; Sawchenko PE; Bérod A; Hartman BK; Helle KB; Vanorden DE
J Comp Neurol; 1981 Feb; 196(2):271-85. PubMed ID: 6111572
[TBL] [Abstract][Full Text] [Related]
15. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease.
MacDonald V; Halliday GM
Mov Disord; 2002 Nov; 17(6):1166-73. PubMed ID: 12465053
[TBL] [Abstract][Full Text] [Related]
16. Distribution of catecholamine-containing neurons in the normal human hypothalamus.
Spencer S; Saper CB; Joh T; Reis DJ; Goldstein M; Raese JD
Brain Res; 1985 Feb; 328(1):73-80. PubMed ID: 2857591
[TBL] [Abstract][Full Text] [Related]
17. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
[TBL] [Abstract][Full Text] [Related]
18. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
19. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL
Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
[TBL] [Abstract][Full Text] [Related]
20. Neuromelanin and Parkinson's disease.
Marsden CD
J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
